Target intelligence / Profile preview

Phosphatidylinositol-glycan biosynthesis class F protein (PIGF)

Target
PIGF
Molecular classification
Enzyme, Transferase (specifically, ethanolaminephosphotransferase), GPI-anchor biosynthesis pathway component
01

Overview

Phosphatidylinositol-glycan biosynthesis class F protein (PIGF) is an enzyme that acts as a stabilizing subunit within the ethanolamine phosphate transferase complexes involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which are glycolipids that tether proteins to the cell membrane. It specifically participates in the transfer of ethanolamine phosphate to the third and second mannose residues in the GPI precursor, in association with the PIGO and PIGG proteins. PIGF’s activity is crucial for the proper post-translational modification of surface proteins, especially in blood cells, and mutations in its gene can result in multiple congenital disorders affecting nails, bones, intellectual development, and seizure susceptibility.

Other names
GPI ethanolamine phosphate transferase, stabilizing subunitPIG-FGPI ethanolamine phosphate transferase 2, stabilizing subunitGPI ethanolamine phosphate transferase 3, stabilizing subunitGPI11 homologOORS
02

Biological functions

GPI-anchor biosynthesisTransfer of ethanolamine phosphate to mannose residues in GPI-anchor core structurePost-translational modification of proteins (membrane anchoring)
03

Disease associations

OnychodystrophyOsteodystrophyImpaired intellectual developmentSeizures syndromePre-eclampsia
04

Safety considerations

Mutations can cause hereditary disease phenotypes such as intellectual disability, osteodystrophy, onychodystrophy, and seizure syndromes

Beyond the preview

Go deeper on Phosphatidylinositol-glycan biosynthesis class F protein (PIGF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-glycan biosynthesis class F protein (PIGF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call